# Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease

> **NCT01804959** · PHASE2 · UNKNOWN · sponsor: **Singapore General Hospital** · enrollment: 40 (actual)

## Conditions studied

- Systemic Sclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Vivomixx probiotics

## Key facts

- **NCT ID:** NCT01804959
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2017-11
- **Final completion:** 2020-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01804959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01804959, "Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01804959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*